These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1053886)

  • 1. Preliminary trial of cyclophosphamide in the management of hemophiliacs with factor VIII inhibitors.
    Ruggeri ZM; Mannucci PM; Allain JP; Frommel D
    Ann N Y Acad Sci; 1975 Jan; 240():412-8. PubMed ID: 1053886
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of combined factor VIII and cyclophosphamide to suppress antibody to factor VIII in hemophilia.
    Hruby MA; Schulman I
    Blood; 1973 Dec; 42(6):919-23. PubMed ID: 4759918
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Hemophilia: cyclophosphamide and factor VIII concentrate.
    Stein RS
    Ann Intern Med; 1974 Nov; 81(5):706-7. PubMed ID: 4419955
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 7. Prothrombin complex concentrates. Use in treatment of hemophiliacs with factor VIII inhibitors.
    Yolken RH; Hilgartner MW
    Am J Dis Child; 1978 Mar; 132(3):291-3. PubMed ID: 629247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression of patients with acquired factor VIII inhibitors.
    Green D
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):60-1. PubMed ID: 7939780
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic inhibitor of factor VIII and its treatment by immunosuppression.
    Ting HC; Wang F; Por P; Nurulhuda A
    Acta Haematol; 1980; 64(4):236-8. PubMed ID: 6781207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilia in children. Current immunologic status of a pediatric population.
    Carnelli V; Giulotto P; Magnolfi C; Cordini M; Simoni L; Cultrera S; Bardare M
    Scand J Haematol Suppl; 1984; 40():359-65. PubMed ID: 6433462
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia: acquired modifications of the genetic disorder.
    Hampton JW; Warner D
    Ann N Y Acad Sci; 1975 Jan; 240():405-6. PubMed ID: 1053884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs.
    Rizza CR; Matthews JM
    Br J Haematol; 1982 Sep; 52(1):13-24. PubMed ID: 6810911
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII inhibitors in patients with hemophilia A.
    Oren H; Yaprak I; Irken G
    Acta Haematol; 1999; 102(1):42-6. PubMed ID: 10473887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and persistence of antibody to hepatitis-associated (Australia) antigen in patients with hemophilia.
    Seeler RA; Mufson MA
    J Infect Dis; 1971 Mar; 123(3):279-83. PubMed ID: 5000075
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor VIII antibodies: immunosuppressive therapy.
    Green D
    Ann N Y Acad Sci; 1975 Jan; 240():389-99. PubMed ID: 1078622
    [No Abstract]   [Full Text] [Related]  

  • 19. Suggestions for the management of factor VIII inhibitors.
    Rubinger M; Rivard GE; Teitel J; Walker H;
    Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269
    [No Abstract]   [Full Text] [Related]  

  • 20. The management of haemophiliacs who have antibodies to factor VIII.
    Rizza CR
    Scand J Haematol Suppl; 1984; 40():187-93. PubMed ID: 6433451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.